Walmart Inc. (NEO:WMT)

Inozyme Pharma Revenue

Walmart had revenue of $165.61B USD in the quarter ending April 30, 2025, with 2.54% growth. This brings the company's revenue in the last twelve months to $685.09B, up 4.22% year-over-year. In the fiscal year ending January 31, 2025, Walmart had annual revenue of $680.99B with 5.07% growth.

• Revenue (ttm): $685.09B
• Revenue Growth: +4.22%
• P/S Ratio: 1.20
• Revenue / Employee: $326.23K
• Employees: 2,100,000
• Market Cap: 1,138.13B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jan 31, 2025	680.99B	32.86B	5.07%
Jan 31, 2024	648.13B	36.84B	6.03%
Jan 31, 2023	611.29B	38.54B	6.73%
Jan 31, 2022	572.75B	13.60B	2.43%
Jan 31, 2021	559.15B	35.19B	6.72%